Otto Sussmann

Bogota, DC, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.

Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.

Journal: Journal of the International Association of Providers of AIDS Care

Published: March 27, 2026

Nur77 Is Associated With Polyfunctional Properties in Virus-Specific Human CD8+ T Cells.

Nur77 Is Associated With Polyfunctional Properties in Virus-Specific Human CD8+ T Cells.

Journal: European journal of immunology

Published: October 14, 2025

Mpox: Characterization and clinical outcomes of patients in Colombian healthcare institutions.

Mpox: Characterization and clinical outcomes of patients in Colombian healthcare institutions.

Journal: Global epidemiology

Published: October 01, 2024

Reasons for antiretroviral switching in Colombia: A retrospective cohort study.

Reasons for antiretroviral switching in Colombia: A retrospective cohort study.

Journal: International journal of STD & AIDS

Published: July 10, 2023

Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population.

Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population.

Journal: International journal of STD & AIDS

Published: May 03, 2022

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 27, 2020

Association of HIV status with infection by multiple HPV types.

Association of HIV status with infection by multiple HPV types.

Journal: Tropical medicine & international health : TM & IH

Published: August 23, 2018

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 28, 2018

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.

Journal: BMC cancer

Published: January 14, 2014

HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?

HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?

Journal: AIDS reviews

Published: December 22, 2012

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Journal: PloS one

Published: September 26, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026